Hahn B - Search Results

1

Impact of Mepolizumab on Exacerbations in the US Medicare Population.

Sethi S, Bogart M, Corbridge T, Cyhaniuk A, Hahn B. Sethi S, et al. Among authors: hahn b. J Allergy Clin Immunol Pract. 2023 Feb;11(2):546-554.e2. doi: 10.1016/j.jaip.2022.10.021. Epub 2022 Oct 27. J Allergy Clin Immunol Pract. 2023. PMID: 36377070 Free article.

2

Real-World Effectiveness of Mepolizumab in Patients with Severe Asthma: An Examination of Exacerbations and Costs.

Llanos JP, Ortega H, Bogart M, Packnett ER, Manjelievskaia J, Bell CF, Hahn B. Llanos JP, et al. Among authors: hahn b. J Asthma Allergy. 2020 Jan 29;13:77-87. doi: 10.2147/JAA.S236609. eCollection 2020. J Asthma Allergy. 2020. PMID: 32099413 Free PMC article.

3

Impact of mepolizumab on exacerbations in severe asthma: Results from a U.S. insurance claims data base.

Ortega H, Hahn B, Bogart M, Bell CF, Bancroft T, Chastek B, Llanos JP. Ortega H, et al. Among authors: hahn b. Allergy Asthma Proc. 2020 Sep 1;41(5):341-347. doi: 10.2500/aap.2020.41.200043. Allergy Asthma Proc. 2020. PMID: 32867888

4

Real-World Reductions in Oral Corticosteroid Use in the USA Following Mepolizumab Therapy for Severe Asthma.

Silver J, Bogart M, Packnett E, Wu J, McMorrow D, Hahn B. Silver J, et al. Among authors: hahn b. J Asthma Allergy. 2020 Dec 16;13:689-699. doi: 10.2147/JAA.S275944. eCollection 2020. J Asthma Allergy. 2020. PMID: 33364788 Free PMC article.

5

Real-world effectiveness of mepolizumab in patients with severe asthma and associated comorbidities.

Casale T, Molfino NA, Silver J, Bogart M, Packnett E, McMorrow D, Wu J, Hahn B. Casale T, et al. Among authors: hahn b. Ann Allergy Asthma Immunol. 2021 Sep;127(3):354-362.e2. doi: 10.1016/j.anai.2021.05.021. Epub 2021 May 24. Ann Allergy Asthma Immunol. 2021. PMID: 34038773 Free article.

6

Factors leading to discontinuation of biologic therapy in patients with severe asthma.

Silver J, Bogart M, Molfino NA, Siddall J, Small M, Hanson M, Hahn B. Silver J, et al. Among authors: hahn b. J Asthma. 2022 Sep;59(9):1839-1849. doi: 10.1080/02770903.2021.1971700. Epub 2021 Sep 6. J Asthma. 2022. PMID: 34486912 Free article.

7

A real-world study of inhaled corticosteroid use in patients with severe eosinophilic asthma treated with mepolizumab.

Corren J, Silver J, Molfino NA, Bogart M, Packnett E, McMorrow D, Wu J, Hahn B. Corren J, et al. Among authors: hahn b. Ann Allergy Asthma Immunol. 2022 Feb;128(2):184-192.e1. doi: 10.1016/j.anai.2021.11.005. Epub 2021 Nov 10. Ann Allergy Asthma Immunol. 2022. PMID: 34774737 Free article.

8

Real-world impact of mepolizumab in patients with life-threatening asthma: US insurance claims database analysis.

Silver J, Molfino N, Bogart M, Packnett ER, McMorrow D, Wu J, Hahn B. Silver J, et al. Among authors: hahn b. Clin Ther. 2021 Dec;43(12):2064-2073. doi: 10.1016/j.clinthera.2021.10.010. Epub 2021 Dec 7. Clin Ther. 2021. PMID: 34893348 Free article.

9

Impact of mepolizumab in patients with high-burden severe asthma within a managed care population.

Lugogo NL, Bogart M, Corbridge T, Packnett ER, Wu J, Hahn B. Lugogo NL, et al. Among authors: hahn b. J Asthma. 2023 Apr;60(4):811-823. doi: 10.1080/02770903.2022.2102036. Epub 2022 Jul 21. J Asthma. 2023. PMID: 35853158 Free article.

10

Profiling Disease and Economic Burden in CRSwNP Using Machine Learning.

Bhattacharyya N, Silver J, Bogart M, Kponee-Shovein K, Cheng WY, Cheng M, Cheung HC, Duh MS, Hahn B. Bhattacharyya N, et al. Among authors: hahn b. J Asthma Allergy. 2022 Sep 30;15:1401-1412. doi: 10.2147/JAA.S378469. eCollection 2022. J Asthma Allergy. 2022. PMID: 36211639 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,274 results

Search Page

Filters